Skip to main content
All lobbying filings

SPLITOAK STRATEGIES LLC

Lobbying for CARIS SCIENCE INC · Providing precision medicine services to patients battling aggressive cancers.

 Filing 4th Quarter - Report
4th Quarter (Oct 1 - Dec 31) 2025 · Texas · House · Senate · $40,000.00 income · posted Jan 20, 2026

Official filing document

 Bills named in this filing 2
 Lobbying activity 2
Medicare/Medicaid

Role of molecular profiling in cancer care; access to molecular profiling technologies and multi-cancer testing in Medicare; HR 5081, Telehealth Modernization Act, prior authorization reform in Medicare and appropriate reimbursement for cutting edge cancer diagnostic testing; HR 5269 RESULTS Act

Health Issues

Role of Artificial Intelligence and technology in cancer diagnostics and treatment; Value of precision medicine and blood-based diagnostic tools; Appropriate standards in oversight of lab-developed tests

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem